Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma.
Chevli N, Chiang SB, Farach AM, Haque W, Satkunasivam R, Bernicker EH, Pino R, Butler EB, Teh BS. Chevli N, et al. Among authors: satkunasivam r. Adv Radiat Oncol. 2021 May 21;6(6):100719. doi: 10.1016/j.adro.2021.100719. eCollection 2021 Nov-Dec. Adv Radiat Oncol. 2021. PMID: 34934851 Free PMC article.
Localized prostate cancer: An analysis of the Centers for Disease Control and Prevention Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP).
Celtik K, Wallis CJD, Lo M, Lim K, Lipscomb J, Fleming S, Wu XC, Anderson RT, Thompson TD, Farach A, Hamilton AS, Miles BJ, Satkunasivam R. Celtik K, et al. Among authors: satkunasivam r. Can Urol Assoc J. 2022 Jul;16(7):E391-E398. doi: 10.5489/cuaj.7580. Can Urol Assoc J. 2022. PMID: 35230935 Free PMC article.
Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation.
Riveros C, Ranganathan S, Haque W, Huang E, Xu J, Kulkarni GS, Geng M, Anis M, Muhammad T, Chan KS, Farach A, Teh BS, Miles BJ, Klaassen Z, Sonpavde GP, Wallis CJD, Satkunasivam R. Riveros C, et al. Among authors: satkunasivam r. Can Urol Assoc J. 2024 Feb;18(2):17-24. doi: 10.5489/cuaj.8386. Can Urol Assoc J. 2024. PMID: 37931278 Free PMC article.
Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy.
Riveros C, Ranganathan S, Xu J, Chang C, Kaushik D, Morgan M, Miles BJ, Muhammad T, Anis M, Aghazadeh M, Zhang J, Efstathiou E, Klaassen Z, Brooks MA, Rini B, Wallis CJD, Satkunasivam R. Riveros C, et al. Among authors: satkunasivam r. Urol Oncol. 2023 Mar;41(3):150.e1-150.e9. doi: 10.1016/j.urolonc.2022.11.022. Epub 2023 Jan 5. Urol Oncol. 2023. PMID: 36610815
Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach.
Hall ME, Bhindi B, Luckenbaugh AN, Laviana AA, Moses KA, Satkunasivam R, Rini B, Klaassen Z, Wallis CJD. Hall ME, et al. Among authors: satkunasivam r. Cancer Causes Control. 2021 Jul;32(7):675-680. doi: 10.1007/s10552-021-01435-z. Epub 2021 May 8. Cancer Causes Control. 2021. PMID: 33963938
Not So "Active" Surveillance.
Wallis CJD, Klotz L, Satkunasivam R, Klaassen Z. Wallis CJD, et al. Among authors: satkunasivam r. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):716-717. doi: 10.1016/j.ijrobp.2021.01.030. Int J Radiat Oncol Biol Phys. 2021. PMID: 34089678 No abstract available.
123 results